Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
In this report, the United States Biopharmaceuticals market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2019 and 2025.
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Biopharmaceuticals in these regions, from 2018 to 2025 (forecast).
United States Biopharmaceuticals market competition by top manufacturers/players, with Biopharmaceuticals sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Monoclonal Antibodies
Interferon
Colony-Stimulating Factor
Erythropoietin
Insulin
Vaccines
Growth Hormones
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Biopharmaceuticals for each application, including
Tumor
Diabetes
Cardiovascular
Hemophilia
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
United States Biopharmaceuticals Market Report 2019
1 Biopharmaceuticals Overview
1.1 Product Overview and Scope of Biopharmaceuticals
1.2 Classification of Biopharmaceuticals by Product Category
1.2.1 United States Biopharmaceuticals Market Size (Sales Volume) Comparison by Type (2014-2024)
1.2.2 United States Biopharmaceuticals Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Monoclonal Antibodies
1.2.4 Interferon
1.2.5 Colony-Stimulating Factor
1.2.6 Erythropoietin
1.2.7 Insulin
1.2.8 Vaccines
1.2.9 Growth Hormones
1.2.10 Others
1.3 United States Biopharmaceuticals Market by Application/End Users
1.3.1 United States Biopharmaceuticals Market Size (Consumption) and Market Share Comparison by Application (2014-2024)
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Others
1.4 United States Biopharmaceuticals Market by Region
1.4.1 United States Biopharmaceuticals Market Size (Value) Comparison by Region (2014-2024)
1.4.2 The West Biopharmaceuticals Status and Prospect (2014-2024)
1.4.3 Southwest Biopharmaceuticals Status and Prospect (2014-2024)
1.4.4 The Middle Atlantic Biopharmaceuticals Status and Prospect (2014-2024)
1.4.5 New England Biopharmaceuticals Status and Prospect (2014-2024)
1.4.6 The South Biopharmaceuticals Status and Prospect (2014-2024)
1.4.7 The Midwest Biopharmaceuticals Status and Prospect (2014-2024)
1.5 United States Market Size (Value and Volume) of Biopharmaceuticals (2014-2024)
1.5.1 United States Biopharmaceuticals Sales and Growth Rate (2014-2024)
1.5.2 United States Biopharmaceuticals Revenue and Growth Rate (2014-2024)
2 United States Biopharmaceuticals Market Competition by Players/Suppliers
2.1 United States Biopharmaceuticals Sales and Market Share of Key Players/Suppliers (2014-2019)
2.2 United States Biopharmaceuticals Revenue and Share by Players/Suppliers (2014-2019)
2.3 United States Biopharmaceuticals Average Price by Players/Suppliers (2014-2019)
2.4 United States Biopharmaceuticals Market Competitive Situation and Trends
2.4.1 United States Biopharmaceuticals Market Concentration Rate
2.4.2 United States Biopharmaceuticals Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Biopharmaceuticals Manufacturing Base Distribution, Sales Area, Product Type
3 United States Biopharmaceuticals Sales (Volume) and Revenue (Value) by Region (2014-2019)
3.1 United States Biopharmaceuticals Sales and Market Share by Region (2014-2019)
3.2 United States Biopharmaceuticals Revenue and Market Share by Region (2014-2019)
3.3 United States Biopharmaceuticals Price by Region (2014-2019)
4 United States Biopharmaceuticals Sales (Volume) and Revenue (Value) by Type (Product Category) (2014-2019)
4.1 United States Biopharmaceuticals Sales and Market Share by Type (Product Category) (2014-2019)
4.2 United States Biopharmaceuticals Revenue and Market Share by Type (2014-2019)
4.3 United States Biopharmaceuticals Price by Type (2014-2019)
4.4 United States Biopharmaceuticals Sales Growth Rate by Type (2014-2019)
5 United States Biopharmaceuticals Sales (Volume) by Application (2014-2019)
5.1 United States Biopharmaceuticals Sales and Market Share by Application (2014-2019)
5.2 United States Biopharmaceuticals Sales Growth Rate by Application (2014-2019)
5.3 Market Drivers and Opportunities
6 United States Biopharmaceuticals Players/Suppliers Profiles and Sales Data
6.1 Roche
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Biopharmaceuticals Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Roche Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2014-2019)
6.1.4 Main Business/Business Overview
6.2 Amgen
6.2.2 Biopharmaceuticals Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Amgen Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2014-2019)
6.2.4 Main Business/Business Overview
6.3 AbbVie
6.3.2 Biopharmaceuticals Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 AbbVie Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2014-2019)
6.3.4 Main Business/Business Overview
6.4 Sanofi-Aventis
6.4.2 Biopharmaceuticals Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Sanofi-Aventis Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2014-2019)
6.4.4 Main Business/Business Overview
6.5 Johnson & Johnson
6.5.2 Biopharmaceuticals Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Johnson & Johnson Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2014-2019)
6.5.4 Main Business/Business Overview
6.6 Pfizer
6.6.2 Biopharmaceuticals Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Pfizer Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2014-2019)
6.6.4 Main Business/Business Overview
6.7 Novo Nordisk
6.7.2 Biopharmaceuticals Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Novo Nordisk Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2014-2019)
6.7.4 Main Business/Business Overview
6.8 Eli Lilly
6.8.2 Biopharmaceuticals Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Eli Lilly Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2014-2019)
6.8.4 Main Business/Business Overview
6.9 Novartis
6.9.2 Biopharmaceuticals Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Novartis Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2014-2019)
6.9.4 Main Business/Business Overview
6.10 Merck
6.10.2 Biopharmaceuticals Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Merck Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2014-2019)
6.10.4 Main Business/Business Overview
7 Biopharmaceuticals Manufacturing Cost Analysis
7.1 Biopharmaceuticals Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Biopharmaceuticals
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Biopharmaceuticals Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Biopharmaceuticals Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Biopharmaceuticals Market Size (Value and Volume) Forecast (2019-2024)
11.1 United States Biopharmaceuticals Sales Volume, Revenue Forecast (2019-2024)
11.2 United States Biopharmaceuticals Sales Volume Forecast by Type (2019-2024)
11.3 United States Biopharmaceuticals Sales Volume Forecast by Application (2019-2024)
11.4 United States Biopharmaceuticals Sales Volume Forecast by Region (2019-2024)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
